Biopharma Business

 Breaking News

Out with the old and in with the new — EU project launched for renewable solvents

  Out with the old and in with the new — EU project launched for renewable solvents

ReSolve — ‘Renewable solvents with high performance in applications and improved toxicity profiles’ — is set to last three years

Read Full Article

FDA approves BioMarin’s manufacturing facility in Cork, Ireland

  FDA approves BioMarin’s manufacturing facility in Cork, Ireland

The Food and Drug Administration (FDA) has approved BioMarin Pharmaceutical’s bulk biologics manufacturing plant, located in Shanbally, Cork, Ireland for

Read Full Article

British manufacturing industry calls on government to rethink Brexit strategy

  British manufacturing industry calls on government to rethink Brexit strategy

British manufacturers are asking the government to negotiate access to the single market and a form of customs union along

Read Full Article

UK’s NICE approves Roche’s breast cancer drug Kadcyla for routine use

  UK’s NICE approves Roche’s breast cancer drug Kadcyla for routine use

The UK National Institute for Health and Care Excellence (NICE) has granted approval for Roche’s breast cancer drug Kadcyla for

Read Full Article

MSD investment confirms thriving biopharmaceutical hub

  MSD investment confirms thriving biopharmaceutical hub

BioPharmaChem Ireland, the Ibec group that represents business in the sector, said the announcement of MSD to invest €280 million

Read Full Article

Novo Nordisk wins European approval for Refixia

  Novo Nordisk wins European approval for Refixia

Novo Nordisk has won EU approval for its new haemophilia drug Reflixia and is planning its first European launches in

Read Full Article

EMA to Evaluate Liver Problems Linked to Zinbryta

  EMA to Evaluate Liver Problems Linked to Zinbryta

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) discussed the safety reviews of a variety of medications during its

Read Full Article

EC approves Johnson & Johnson’s $30bn acquisition of Actelion

  EC approves Johnson & Johnson’s $30bn acquisition of Actelion

The European Commission (EC) has approved Johnson & Johnson’s proposed $30bn acquisition of Actelion Pharmaceuticals, subject to conditions J&J signed

Read Full Article

Health Beacon to hire 20 new staff in Dublin

  Health Beacon to hire 20 new staff in Dublin

Medtech firm Health Beacon, whose backers include Bill McCabe’s Oyster Capital, will more than double its Dublin workforce with the

Read Full Article

New EMA guidelines on biosimilar medicines

  New EMA guidelines on biosimilar medicines

The European Medicines Agency (EMA) and the European Commission have published an information guide for healthcare professionals on biosimilar medicines. Biosimilars are

Read Full Article

Expats returning post Brexit could cost NHS £500m

  Expats returning post Brexit could cost NHS £500m

The NHS could be faced with having to pay nearly half a billion pounds more if British expats decide to

Read Full Article

Three new apprenticeship schemes seek to plug skills gap

  Three new apprenticeship schemes seek to plug skills gap

Three new apprenticeship schemes have been introduced in the medtech sector as part of Government attempts to plug the skills

Read Full Article

Pfizer’s Meningococcal Group B vaccine, Trumenba, gets approval in Europe

  Pfizer’s Meningococcal Group B vaccine, Trumenba, gets approval in Europe

Pfizer has secured approval the European Commission (EC) for TRUMENBA (Meningococcal Group B Vaccine) for preventing invasive meningococcal disease caused

Read Full Article

Cambrex announces investment and expansion in Sweden

  Cambrex announces investment and expansion in Sweden

Cambrex, manufacturer of small molecule active pharmaceutical ingredients (APIs), has announced it is investing in new capacity and continuous flow

Read Full Article

EU review for Sandoz’ Humira, Remicade biosimilars

  EU review for Sandoz’ Humira, Remicade biosimilars

European regulators have accepted for review Sandoz’ marketing applications for biosimilars to AbbVie’s Humira (adalimumab) and Janssen’s Remicade (infliximab). The

Read Full Article

Aptar Pharma’s electronic lockout device approved by EMA

  Aptar Pharma’s electronic lockout device approved by EMA

The European Medicines Agency (EMA) has approved Aptar Pharma’s integrated electronic nasal lockout device (e-Lockout) following a multi-year development with Takeda

Read Full Article

Brilique (ticagrelor) new formulation gains European approval

  Brilique (ticagrelor) new formulation gains European approval

The European Commission (EC) has granted marketing authorisation for AstraZeneca’s Brilique (ticagrelor) orodispersible tablets (ODT) as a new method of

Read Full Article

Making biological drugs with spider silk protein

  Making biological drugs with spider silk protein

Researchers at Karolinska Institutet in Sweden have managed to synthesise lung surfactant, a drug used in the care of preterm

Read Full Article

Isolated Greek villages reveal genetic secrets that protect against heart disease

  Isolated Greek villages reveal genetic secrets that protect against heart disease

A genetic variant that protects the heart against cardiovascular disease has been discovered by researchers at the Wellcome Trust Sanger

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements